Kolexia
Sabiani Laura
Gynécologie
Centre Paoli-Calmettes
Marseille, France
54 Activités
110 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Tumeurs de l'ovaire Tumeurs du col de l'utérus Carcinome épithélial de l'ovaire Carcinomes Complications postopératoires Métastase lymphatique Infections à papillomavirus Vaccine

Industries

MSD
2 collaboration(s)
Dernière en 2020
Olympus
1 collaboration(s)
Dernière en 2022
Daiichi Sankyo
1 collaboration(s)
Dernière en 2022
GSK
1 collaboration(s)
Dernière en 2023

Dernières activités

A computer synoptic operative report versus a report dictated by a surgeon in advanced ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society   08 février 2024
Neoadjuvant chemotherapy for breast cancer: Pathologic response rates but not tumor size, has an independent prognostic impact on survival.
Cancer medicine   07 février 2024
Is minimally invasive surgical approach a reasonable option in apparent early stage epithelial ovarian cancer restaging? Results from a multicentric retrospective study.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology   28 janvier 2024
Triple-negative and Her2-positive breast cancer in women aged 70 and over: prognostic impact of age according to treatment.
Frontiers in oncology   15 décembre 2023
Laura SABIANI - La chirurgie, cancers gynécologiques
Youtube @ Institut Paoli-Calmettes   10 octobre 2023
Enhanced Recovery after Surgery and Endometrial Cancers: Results from an Initial Experience Focused on Elderly Patients.
Cancers   19 juin 2023
CHIPPI: Phase III Randomized Clinical Trial Evaluating Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer Considering Two Different Settings: Primary Debulking Surgery (PDS) and Interval Debulking Surgery (IDS)
Essai Clinique (Centre Oscar-Lambret)   06 décembre 2022
Pathological complete response rate and disease-free survival after neoadjuvant chemotherapy in patients with HER2-low and HER2-0 breast cancers.
European journal of cancer (Oxford, England : 1990)   28 septembre 2022
Neoadjuvant Chemotherapy for Breast Cancer: Evolution of Clinical Practice in a French Cancer Center Over 16 Years and Pathologic Response Rates According to Tumor Subtypes and Clinical Tumor Size: Retrospective Cohort Study.
Journal of surgery and research   14 septembre 2022
Mastectomy and Immediate Breast Reconstruction with Pre-Pectoral or Sub-Pectoral Implant: Assessing Clinical Practice, Post-Surgical Outcomes, Patient's Satisfaction and Cost.
Journal of surgery and research   09 septembre 2022